US EditionPublished • loading... • Updated
Wegovy Protects the Heart in Danes without Diabetes
Summary by medicinsketidsskrifter.dk
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
CARDIOLOGICAL JOURNAL Diet medication protects the heart in Danes without diabetes Wegovy (semaglutide 2.4 mg) reduces the risk of heart attack, stroke or death from any cause by 47 percent in adults who are overweight or obese without diabetes, shows a new Danish registry study. The results add to a growing body of evidence that collectively supports that semaglutide has a significant cardiovascular protective effect, says chief physician Micha…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
